BIOXCEL THERAPEUTICS INC (BTAI) Stock Cash Flow
NASDAQ:BTAI - Nasdaq - US09075P2048 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -40.06M | -59.60M | -179.05M | -165.76M | -106.93M | |||
| Depreciation Amortization | 307.00K | 309.00K | 318.00K | 330.00K | 300.00K | |||
| Change In Working Capital | -11.57M | -5.72M | 2.31M | 10.67M | 4.98M | |||
| Interest Paid | N/A | 7.97M | 7.55M | 2.70M | 40.00K | |||
| Other non cash items | -15.04M | -7.01M | 21.42M | 19.42M | 19.50M | |||
| OPERATING CASH FLOW | -66.36M | -72.03M | -155.01M | -135.34M | -82.15M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | -20.00K | -140.00K | -450.00K | |||
| INVESTING CASH FLOW | N/A | N/A | -20.00K | -140.00K | -450.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | -2.50M | N/A | 98.60M | N/A | |||
| Stock Issued/Repurchased | 26.95M | 39.69M | 27.54M | 280.00K | 102.45M | |||
| Other Financing Activity | -1.22M | -528.00K | -1.02M | -2.65M | N/A | |||
| FINANCING CASH FLOW | 23.24M | 36.66M | 26.52M | 96.24M | 102.45M | |||
| CHANGE IN CASH | -43.13M | -35.37M | -128.50M | -39.24M | 19.85M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -66.36M | -72.03M | -155.01M | -135.34M | -82.15M | |||
| Capital Expenditure | N/A | N/A | -20.00K | -140.00K | -450.00K | |||
| FREE CASH FLOW | -66.36M | -72.03M | -155.03M | -135.48M | -82.60M | |||
All data in USD